BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24399670)

  • 1. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD010693. PubMed ID: 29197071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010693. PubMed ID: 36625492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD010693. PubMed ID: 31596946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D; Liu B; Tao W; Hao Z; Liu M
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009580. PubMed ID: 26497361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.
    Zonneveld TP; Richard E; Vergouwen MD; Nederkoorn PJ; de Haan R; Roos YB; Kruyt ND
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD007858. PubMed ID: 30024023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
    Kamal AK; Naqvi I; Husain MR; Khealani BA
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD008076. PubMed ID: 21249700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
    Liu J; Zhang J; Wang LN
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009622. PubMed ID: 30376593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack.
    Mackay-Lyons M; Thornton M; Ruggles T; Che M
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008656. PubMed ID: 23543566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
    Naqvi IA; Kamal AK; Rehman H
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2014 Aug; (8):CD009622. PubMed ID: 25097101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triflusal for preventing serious vascular events in people at high risk.
    Costa J; Ferro JM; Matias-Guiu J; Alvarez-Sabin J; Torres F
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004296. PubMed ID: 16034926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009622. PubMed ID: 23450607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
    Liu J; Wang LN; Ma X; Ji X
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009622. PubMed ID: 27701753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrates for primary prevention of cardiovascular disease events.
    Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack.
    Coveney S; McCabe JJ; Murphy S; O'Donnell M; Kelly PJ
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012825. PubMed ID: 32392374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.